Mitochondrial Dysfunction Induces Sarm1-Dependent Cell Death in Sensory Neurons

Mitochondrial dysfunction is the underlying cause of many neurological disorders, including peripheral neuropathies. Mitochondria rely on a proton gradient to generate ATP and interfering with electron transport chain function can lead to the deleterious accumulation of reactive oxygen species (ROS). Notably, loss of mitochondrial potential precedes cellular demise in several programmed cell destruction pathways, including axons undergoing Wallerian degeneration. Here, we demonstrate that mitochondrial depolarization triggers axon degeneration and cell death in primary mouse sensory neurons. These degenerative events are not blocked by inhibitors of canonical programmed cell death pathways such as apoptosis, necroptosis, and parthanatos. Instead, the axodestructive factor Sarm1 is required for this axon degeneration and cell death. In the absence of Sarm1, the mitochondrial poison CCCP still induces depolarization of mitochondria, ATP depletion, calcium influx, and the accumulation of ROS, yet cell death and axon degeneration are blocked. The survival of these neurons despite the accumulation of ROS indicates that Sarm1 acts downstream of ROS generation. Indeed, loss of Sarm1 protects sensory neurons and their axons from prolonged exposure to ROS. Therefore, Sarm1 functions downstream of ROS to induce neuronal cell death and axon degeneration during oxidative stress. These findings highlight the central role for Sarm1 in a novel form of programmed cell destruction that we term sarmoptosis.

[1]  Mackenzie W. Mathis,et al.  Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS , 2014, Neuron.

[2]  N. Renier,et al.  Regulation of Axon Degeneration after Injury and in Development by the Endogenous Calpain Inhibitor Calpastatin , 2013, Neuron.

[3]  R. Casson,et al.  Mechanisms of neuroprotection by glucose in rat retinal cell cultures subjected to respiratory inhibition. , 2013, Investigative ophthalmology & visual science.

[4]  M. Sakaguchi,et al.  SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria , 2013, Molecular biology of the cell.

[5]  J. Milbrandt,et al.  Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions , 2013, The Journal of Neuroscience.

[6]  T. Schwarz Mitochondrial trafficking in neurons. , 2013, Cold Spring Harbor perspectives in biology.

[7]  S. Jang,et al.  Mitochondrial swelling and microtubule depolymerization are associated with energy depletion in axon degeneration , 2013, Neuroscience.

[8]  Roger A. Moore,et al.  Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. , 2013, Immunity.

[9]  J. Milbrandt,et al.  Aberrant Schwann Cell Lipid Metabolism Linked to Mitochondrial Deficits Leads to Axon Degeneration and Neuropathy , 2013, Neuron.

[10]  Jianzhu Chen,et al.  T-cell death following immune activation is mediated by mitochondria-localized SARM , 2012, Cell Death and Differentiation.

[11]  L. Galluzzi,et al.  Mitochondria: master regulators of danger signalling , 2012, Nature Reviews Molecular Cell Biology.

[12]  A. Federico,et al.  Mitochondria, oxidative stress and neurodegeneration , 2012, Journal of the Neurological Sciences.

[13]  J. Kaminker,et al.  Spatially Coordinated Kinase Signaling Regulates Local Axon Degeneration , 2012, The Journal of Neuroscience.

[14]  A. M. van der Bliek,et al.  Mitochondrial Fission, Fusion, and Stress , 2012, Science.

[15]  J. Arenas,et al.  Mitochondrial respiratory chain dysfunction: implications in neurodegeneration. , 2012, Free radical biology & medicine.

[16]  Mary A. Logan,et al.  dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway , 2012, Science.

[17]  Wei Wu,et al.  Necroptosis: an emerging form of programmed cell death. , 2012, Critical reviews in oncology/hematology.

[18]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[19]  S. Gandhi,et al.  Mechanism of Oxidative Stress in Neurodegeneration , 2012, Oxidative medicine and cellular longevity.

[20]  E. Rugarli,et al.  Mitochondrial quality control: a matter of life and death for neurons , 2012, The EMBO journal.

[21]  J. L. Ding,et al.  Targeting of pro-apoptotic TLR adaptor SARM to mitochondria: definition of the critical region and residues in the signal sequence. , 2012, The Biochemical journal.

[22]  Yun Lu,et al.  Control of Nonapoptotic Developmental Cell Death in Caenorhabditis elegans by a Polyglutamine-Repeat Protein , 2012, Science.

[23]  B. Barres,et al.  Axon degeneration: Molecular mechanisms of a self-destruction pathway , 2012, The Journal of cell biology.

[24]  Xinnan Wang,et al.  PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility , 2011, Cell.

[25]  R. Casson,et al.  Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. , 2011, Archives of ophthalmology.

[26]  N. Curtin,et al.  The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice , 2011, Molecular Cancer Therapeutics.

[27]  E. Feldman,et al.  Diabetic neuropathy: cellular mechanisms as therapeutic targets , 2011, Nature Reviews Neurology.

[28]  J. Milbrandt,et al.  Image-based Screening Identifies Novel Roles for IκB Kinase and Glycogen Synthase Kinase 3 in Axonal Degeneration* , 2011, The Journal of Biological Chemistry.

[29]  C. Hetz,et al.  Axonal Degeneration Is Mediated by the Mitochondrial Permeability Transition Pore , 2011, The Journal of Neuroscience.

[30]  L. Martin,et al.  Necrostatin Decreases Oxidative Damage, Inflammation, and Injury after Neonatal HI , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  M. Dyer,et al.  The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. , 2010, Blood.

[32]  J. Milbrandt,et al.  Amyloid Precursor Protein Cleavage-Dependent and -Independent Axonal Degeneration Programs Share a Common Nicotinamide Mononucleotide Adenylyltransferase 1-Sensitive Pathway , 2010, The Journal of Neuroscience.

[33]  S. Lipton,et al.  Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies. , 2010, Cell calcium.

[34]  A. Tuttolomondo,et al.  Neuron protection as a therapeutic target in acute ischemic stroke. , 2009, Current topics in medicinal chemistry.

[35]  Klas Blomgren,et al.  Mitochondrial membrane permeabilization in neuronal injury , 2009, Nature Reviews Neuroscience.

[36]  J. Milbrandt,et al.  Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide , 2009, The Journal of Neuroscience.

[37]  J. Milbrandt,et al.  Nmnat Delays Axonal Degeneration Caused by Mitochondrial and Oxidative Stress , 2008, The Journal of Neuroscience.

[38]  R. Baloh,et al.  Mitochondrial Dynamics and Peripheral Neuropathy , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[39]  Manisha N. Patel,et al.  Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain* , 2007, Journal of Biological Chemistry.

[40]  Richard Kovács,et al.  Mitochondria and neuronal activity. , 2007, American journal of physiology. Cell physiology.

[41]  S. Duvezin-Caubet,et al.  Proteolytic Processing of OPA1 Links Mitochondrial Dysfunction to Alterations in Mitochondrial Morphology* , 2006, Journal of Biological Chemistry.

[42]  K. Mihara,et al.  Regulation of mitochondrial morphology through proteolytic cleavage of OPA1 , 2006, The EMBO journal.

[43]  T. Iijima Mitochondrial membrane potential and ischemic neuronal death , 2006, Neuroscience Research.

[44]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[45]  P. Brookes,et al.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle. , 2004, American journal of physiology. Cell physiology.

[46]  Michael P. Sheetz,et al.  Axonal mitochondrial transport and potential are correlated , 2004, Journal of Cell Science.

[47]  M. Pericak-Vance,et al.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.

[48]  N. Osborne,et al.  The effect of hyperglycemia on experimental retinal ischemia. , 2004, Archives of ophthalmology.

[49]  Caroline Sievers,et al.  Neurites undergoing Wallerian degeneration show an apoptotic-like process with annexin V positive staining and loss of mitochondrial membrane potential , 2003, Neuroscience Research.

[50]  J. Ly,et al.  The mitochondrial membrane potential (Δψm) in apoptosis; an update , 2003, Apoptosis.

[51]  M. Endres,et al.  Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. , 2001, International journal of molecular medicine.

[52]  C. Szabó,et al.  Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. , 1998, Journal of immunology.

[53]  J W Griffin,et al.  Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  J. B. Wolfe,et al.  Localization of the primary metabolic block produced by 2-deoxyglucose. , 1957, The Journal of biological chemistry.

[55]  T. Vanden Berghe,et al.  Programmed necrosis from molecules to health and disease. , 2011, International review of cell and molecular biology.